Both in Pharmaceuticals
AnaptysBio vs Damora Therapeutics
Over the past year ANAB returned −12.9% and DMRA returned −23.1%; their daily moves had a correlation of 0.07.
ANAB −12.9% DMRA −23.1%Growth of $1, one year, split-adjusted
| Metric | ANAB | DMRA |
|---|---|---|
| Price | $46.91 | $21.60 |
| Market cap | $1.40B | $1.33B |
| Today | −2.84% | +0.51% |
| 1 month | −3.3% | +4.6% |
| 6 months | −32.8% | — |
| Year to date | −3.2% | — |
| 1 year | +28.6% | — |
| Revenue growth (YoY) | −8.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −206.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.0× | — |
| Net cash | $286.5M | $540.5M |
| Dividend yield | — | — |
| Volatility (60d) | 41.0% | — |
| Short % of float | 30.6% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).